If you liked this article you might like

The Market Is Not About Washington: Cramer's 'Mad Money' Recap (Wed 8/16/17)

Valeant Pharmaceuticals: Cramer's Top Takeaways

Black, Jewish Goldman Executive Sues Firm Over Discriminatory Practices

Teva Is Cheap, Not Dead

Why Jim Cramer Likes Allergan